CCLA Investment Management Acquires 229,199 Shares of Avantor, Inc. (NYSE:AVTR)

CCLA Investment Management boosted its holdings in Avantor, Inc. (NYSE:AVTRFree Report) by 4.5% in the 4th quarter, HoldingsChannel reports. The firm owned 5,357,703 shares of the company’s stock after purchasing an additional 229,199 shares during the quarter. Avantor makes up approximately 1.8% of CCLA Investment Management’s portfolio, making the stock its 29th largest holding. CCLA Investment Management’s holdings in Avantor were worth $112,940,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Canada Pension Plan Investment Board grew its holdings in shares of Avantor by 6.8% in the second quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock valued at $486,059,000 after purchasing an additional 1,463,695 shares in the last quarter. State Street Corp grew its stake in shares of Avantor by 58.0% in the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock worth $578,666,000 after buying an additional 8,206,695 shares in the last quarter. Janus Henderson Group PLC increased its holdings in shares of Avantor by 18.2% in the 3rd quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock worth $457,710,000 after buying an additional 2,719,615 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Avantor by 7.1% during the 3rd quarter. Geode Capital Management LLC now owns 11,150,788 shares of the company’s stock valued at $287,791,000 after buying an additional 739,667 shares in the last quarter. Finally, 1832 Asset Management L.P. lifted its holdings in shares of Avantor by 1,634.9% in the 2nd quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock valued at $180,839,000 after acquiring an additional 8,038,451 shares during the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Avantor Price Performance

Shares of AVTR stock opened at $21.71 on Wednesday. The stock’s 50-day moving average is $21.49 and its 200 day moving average is $23.36. Avantor, Inc. has a 1-year low of $19.59 and a 1-year high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The company has a market cap of $14.78 billion, a P/E ratio of 47.20, a PEG ratio of 2.75 and a beta of 1.28.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $34.00 target price on shares of Avantor in a report on Thursday, September 26th. Barclays cut their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, October 25th. UBS Group dropped their target price on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research report on Tuesday, October 8th. Robert W. Baird decreased their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Finally, Wells Fargo & Company dropped their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, Avantor currently has an average rating of “Moderate Buy” and an average target price of $27.69.

View Our Latest Stock Report on Avantor

Avantor Company Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Stories

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.